Top

States Try to Obscure Execution Details as Drugmakers Hinder Lethal Injection

Merck signs $922m deal with Opko Health unit for Epstein-Barr vaccine candidate

After Capping Insulin Copays, Colorado Sets Its Sights on EpiPens

Almond, Soy Drinks Can Be Called Milk, FDA Proposes

GSK and Vir Biotech amend COVID-19 research partnership

Tag: Acrivon

Acrivon cuts IPO price to raise $99M for plan to revive old Lilly cancer drug

November 15, 2022

Via: Biopharma Dive

Like a number of the other biotech startups to reach Wall Street this year, Acrivon is primarily focused on a single drug and getting it to market. Its lead drug is prexasertib, a small molecule targeting a pair of enzymes […]